Intra-Osseous Co-Transplant of UCB and hMSC
Public ClinicalTrials.gov record NCT02181478. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Intra-osseous Co-transplant of Cord Blood and Mesenchymal Stromal Cells: A Feasibility Study
Study identification
- NCT ID
- NCT02181478
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Early Phase 1
- Lead sponsor
- Case Comprehensive Cancer Center
- Other
- Enrollment
- 6 participants
Conditions and interventions
Conditions
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
- Chronic Myelogenous Leukemia
- Hodgkin Lymphoma
- Lymphoid Malignancies
- Myelodysplastic Syndromes
- Myelofibrosis
- Refractory Chronic Lymphocytic Leukemia
- Refractory Hodgkin Lymphoma
- Refractory Non-Hodgkin Lymphoma
- Relapsed Chronic Lymphocytic Leukemia
- Relapsed Non-Hodgkin Lymphoma
Interventions
- cyclophosphamide Drug
- cyclosporine Drug
- fludarabine phosphate Drug
- mesenchymal stem cell transplantation Procedure
- mycophenolate mofetil Drug
- total-body irradiation Radiation
- umbilical cord blood transplantation Procedure
Drug · Procedure · Radiation
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2015
- Primary completion
- Dec 18, 2019
- Completion
- Feb 6, 2020
- Last update posted
- Dec 3, 2020
2015 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Case Comprehensive Cancer Center | Cleveland | Ohio | 44106-5065 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02181478, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2020 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02181478 live on ClinicalTrials.gov.